CP
Caligan Partners Portfolio holdings
AUM
$515M
This Quarter Return
+13.75%
1 Year Return
+70.09%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$515M
AUM Growth
+$515M
(+7.5%)
Cap. Flow
+$3.12M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
93.96%
Holding
18
New
1
Increased
9
Reduced
2
Closed
1
Top Buys
| 1 |
Merus
MRUS
|
$14.7M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$12.3M |
| 3 |
Revolution Medicines
RVMD
|
$6.32M |
| 4 |
Rezolute
RZLT
|
$6.25M |
| 5 |
Evolus
EOLS
|
$5.63M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$24.3M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$22.1M |
| 3 |
Mineralys Therapeutics
MLYS
|
$1.79M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.16B
| $136M | 26.13% | 1,436,878 | – | – |
|
2
Liquidia Corp
LQDA
$2.38B
| $101M | 19.45% | 8,118,892 +300 | +0% | +$3.74K |
|
3
Exelixis
EXEL
$10.1B
| $67.2M | 12.93% | 1,525,730 | – | – |
|
|
4
Agios Pharmaceuticals
AGIO
$2.19B
| $35.6M | 6.85% | 1,071,258 +369,978 | +53% | +$12.3M |
|
|
5
Merus
MRUS
$4.98B
| $34.6M | 6.64% | 656,999 +280,045 | +74% | +$14.7M |
|
|
6
Evolus
EOLS
$494M
| $30.8M | 5.92% | 3,341,970 +610,816 | +22% | +$5.63M |
|
|
7
Mineralys Therapeutics
MLYS
$1.03B
| $27.3M | 5.25% | 2,017,352 -132,315 | -6% | -$1.79M |
|
|
8
Revolution Medicines
RVMD
$7.1B
| $23.4M | 4.5% | 636,835 +171,835 | +37% | +$6.32M |
|
9
Anika Therapeutics
ANIK
$135M
| $15.2M | 2.92% | 1,435,130 | – | – |
|
|
ABVX
10
Abivax
ABVX
$6.12B
| $12.8M | 2.46% | 1,674,400 +405,281 | +32% | +$3.1M |
|
11
Y-mAbs Therapeutics
YMAB
$388M
| $10.6M | 2.03% | 2,342,609 | – | – |
|
|
12
Rezolute
RZLT
$619M
| $6.88M | 1.32% | 1,543,014 +1,401,705 | +992% | +$6.25M |
|
|
13
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.72M | 1.1% | 638,908 -2,468,761 | -79% | -$22.1M |
|
14
Verrica Pharmaceuticals
VRCA
$52.8M
| $4.9M | 0.94% | 9,239,119 +246,165 | +3% | +$130K |
|
15
Tyra Biosciences
TYRA
$675M
| $1.82M | 0.35% | 189,950 +164,950 | +660% | +$1.58M |
|
16
Aura Biosciences
AURA
$389M
| $1.25M | 0.24% | +200,000 | New | +$1.25M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| – | – | -3,052,538 | Closed | -$24.3M |
|
18
SELLAS Life Sciences
SLS
$202M
| – | – | 0 | – | – |
|